chrisvoncsefalvay/vaers-outcomes huggingface dataset:
tired; nauseated; headache; fever; redness in the area; swollen mouth; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (redness in the area), MOUTH SWELLING (swollen mouth), FATIGUE (tired), NAUSEA (nauseated) and HEADACHE (headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-May-2021, the patient experienced ERYTHEMA (redness in the area) and MOUTH SWELLING (swollen mouth). On an unknown date, the patient experienced FATIGUE (tired), NAUSEA (nauseated), HEADACHE (headache) and PYREXIA (fever). At the time of the report, ERYTHEMA (redness in the area), MOUTH SWELLING (swollen mouth), FATIGUE (tired), NAUSEA (nauseated), HEADACHE (headache) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication provided. No treatment information provided.   Reporter did not allow further contact
Swelling at site of vaccine, left thigh, 3 x 4 cm in size.
Information has been received from a physician concerning a 13 year old male patient who on 06-JAN-1998 was vaccinated with the first dose of MMR II. On 09-NOV-2000, the patient received the second dose of MMR II. On 04-DEC-2009, laboratory diagnostic tests were performed: IgG: 3.66; IgM 1:40:00 and serum amylase: 646. On 11-DEC-2009, the patient experienced mumps. The patient was afebrile and had parotitis. The outcome of the patient was not reported. Follow up information was received from a physician concerning a 13 year old (also reported as 12 year old) male patient who on 06-JAN-1998 was vaccinated with the first dose of MMR II (dose, route and lot number not reported). On 09-NOV-2000, the patient received the second dose of MMR II (dose, route and lot number not reported). The physician reported that the patient developed mumps on 18-JAN-2010 (previously reported). The physician reported that the patient developed mumps on 18-JAN-2010 (previously reported as 11-DEC-2009). This was diagnosed on 20-JAN-2010. Laboratory test performed on 20-JAN-2010 included IgM (0.55), IgG (6.64) and amylase (56). The patient had bilateral parotitis and it was unknown if the patient had orchitis. The patient did not experience any other symptoms. It was unknown if there were any sequelae. It was unknown if there was exposure to mumps. The third dose of MMR II was not given. Additional information has been requested.
Sore arm; Feeling really achy and shaky; Feeling really achy and shaky; This is a spontaneous report from a non-contactable consumer, the patient. A 17-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24Jun2021 at 09:15 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient reported to have gotten drunk the night before. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Jun2021 at 09:15 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 24Jun2021 at 22:00 the patient experienced sore arm and feeling really achy and shaky. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcomes of the events sore arm and feeling really achy and shaky were not recovered at the time of this report.  No follow-up attempts are possible; information about lot number cannot be obtained. No further information is expected.
Pt rec'd influenza and pneumococcal vaccines L upper arm 11/7 called 11/8 reporting pain no fever, no local warmth. Seen 11/9 c/o fever, responding to ibuprofen 2 areas erythema L upper arm slightly warm, very tender. CBC and blood culture drawn. Cephalexin 500mg bid x 7 days; resolution of fever 24 hrs resolving pain and redness 5 days.
Flu-like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024M20A and 028L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In February 2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms). In February 2021, INFLUENZA LIKE ILLNESS (Flu-like symptoms) had resolved.            No concomitant medications were reported.  Treatment information was not provided. 12 hours after receiving second dose of vaccine patient had flu like symptoms which lasted for 24 hours.   This case was linked to MOD-2022-439259 (Patient Link).
Dont remember if I had the 2nd shot; This non-serious case was reported by a consumer and described the occurrence of incomplete course of vaccination in a 73-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (1st dose received on an unknown date years ago).   On an unknown date, the patient did not received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced incomplete course of vaccination (Verbatim: Dont remember if I had the 2nd shot). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 26-APR-2023 The patient reported that he or she received Shingles vaccine years ago but did not remember if he or she received second dose. The patient wanted to know should he or she receive the second dose. Till the time of reporting, the patient did not receive the 2nd dose of Shingrix vaccine, which led to incomplete course of vaccination.
w/in 5 to 15min of vax pt felt weak, pale, diaphoretic & stated that legs felt like tree trunks, dizziness, lightheadedness & had to sit down;BP nl;legs felt heavy, sore & tender;h/a;weak grip;almost unable to walk;poss polymyositis or GBS;
patient did not feel well for about 3 days; Initial information received on 06-Oct-2021 regarding an unsolicited valid social media non-serious case from a consumer via Social Media.  This case involves an unknown age and gender patient who did not feel well for about three days (malaise), after receiving INFLUENZA VACCINE and Coronavirus disease (COVID-19) VACCINE.  The patient's past medical treatments, vaccinations, concomitant medications and family history were not provided.   It is unknown if the patient had any medical history, concomitant disease or risk factor.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer batch number and expiry date not reported via unknown route in unknown administration site and a booster dose of suspect COVID-19 VACCINE not produced by Sanofi Pasteur batch number and expiry date not reported via unknown route in unknown administration site for prophylactic vaccinations.  On an unknown date, the patient did not feel well for about three days (malaise/ non-serious event) (unknown latency) following the administration of INFLUENZA VACCINE and of COVID-19 VACCINE.  It was reported "I got my flu shot and. Covid booster at the same time. Didn't feel well for about 3 days. Don't do what I did."  It is unknown if the patient experienced any additional symptoms/ events.   It is unknown if there were lab data/ results available.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome of the reported event was unknown.  There will be no information on the batch number for this case.
weakness in both legs; injection site redness; headache; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (injection site redness), HEADACHE (headache), FATIGUE (fatigue) and MUSCULAR WEAKNESS (weakness in both legs) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site redness), HEADACHE (headache) and FATIGUE (fatigue). On 15-Feb-2021, the patient experienced MUSCULAR WEAKNESS (weakness in both legs). At the time of the report, VACCINATION SITE ERYTHEMA (injection site redness), HEADACHE (headache), FATIGUE (fatigue) and MUSCULAR WEAKNESS (weakness in both legs) outcome was unknown.
Information has been received from a physician concerning a male who was vaccinated with ZOSTAVAX. Subsequently the patient experienced cough. This is one of two reports from the same source. Additional information has been requested.
positive COVID-19 test with no symptoms; positive COVID-19 test with no symptoms; This is a spontaneous report from a contactable Nurse(patient). A 47-year old female patient received second dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, lot number EK9231), intramuscularly on 16Jan2021 08:00 at single dose left arm, and first dose(lot number EK5730), intramuscularly on 29Dec2020 08:00 at single dose, left arm for covid-19 immunization. The patient's medical history and concomitant medications reported as no. Family medical history reported as no. Patient had a negative COVID test on 29Dec2020 prior to receiving the COVID-19 Vaccine. She received first dose of Pfizer COVID-19 Vaccine on 29Dec2020. Second dose of COVID-19 Vaccine received on 16Jan2021. She said that she tested negative after the 1st dose. The patient had a positive COVID test on 18Jan2021. The patient had not had any contact with positive patients or people. Seriousness reported as medically significant because she didn't know what comes of it. Causality reported as yes because she had no contact with anyone who had been COVID positive. Her whole family had been tested and were COVID negative. The patient tried to google it and even a couple nurses wondered if caller's positive COVID test had anything to do with caller's COVID-19 Vaccines. Caller stated she was asymptomatic. She only received the COVID-19 test because she was testing her children. Her children's COVID tests were negative. Caller was highly suspicious it came back as a positive result. Patient didn't know if it was a lab error or the vaccination process and the way the immune system works. COVID test performed was a PCR nasal swab. The outcome of the event was unknown.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Drug ineffective and COVID-19 cannot be totally excluded.  The case will be reassessed if additional information becomes available.
tested positive for Covid19; Loss of appetite; Aching in her neck which got to the other side; Couldn't smell anything; Couldn't taste anything; LIttle bit of headache; Fatigue; Fever; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for Covid19), DECREASED APPETITE (Loss of appetite), NECK PAIN (Aching in her neck which got to the other side), ANOSMIA (Couldn't smell anything) and AGEUSIA (Couldn't taste anything) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Arthritis (In her right knee.) and Hypothyroidism. Concomitant products included THYROID (ARMOUR THYROID) for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced DECREASED APPETITE (Loss of appetite), NECK PAIN (Aching in her neck which got to the other side), ANOSMIA (Couldn't smell anything), AGEUSIA (Couldn't taste anything), HEADACHE (LIttle bit of headache), FATIGUE (Fatigue) and PYREXIA (Fever). On 03-Mar-2021, the patient experienced COVID-19 (tested positive for Covid19). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, COVID-19 (tested positive for Covid19), DECREASED APPETITE (Loss of appetite), NECK PAIN (Aching in her neck which got to the other side), HEADACHE (LIttle bit of headache), FATIGUE (Fatigue) and PYREXIA (Fever) outcome was unknown and ANOSMIA (Couldn't smell anything) and AGEUSIA (Couldn't taste anything) was resolving. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive. On an unknown date, Oxygen saturation: 95 % (Low) pulse oxygen went down to about 95% but didn't go any lower..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient reports that after the first dose her pulse oxygen was 95%..    This case was linked to MOD-2021-244666 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Significant Follow-up received on 01-JUL-2021, Added other events and lab data. On 16-Jul-2021: Follow up received on 16-JUL-2021 contains No New Information. On 28-Jul-2021: Non-significant follow-up case booked in; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. This is also a case with an adverse event of COVID-19. Based on the mechanism of action of mRNA-1273 the event COVID-19 is unlikely related to the vaccine.
achiness, a slight cough and scratch throat, and also his fever reached 101 last evening, but w/ Excedrin pt is now in the 99 range.
Information has been received from a pharmacist referring to a female patient of unknown age. The patient had a history of shingles in the past. On an unspecified date in 2011 the patient was vaccinated with ZOSTAVAX (strength, lot#, dosage and route unspecified). On an unspecified date in May 2014 the patient had an outbreak of shingles. The patient was recovered on an unspecified date. Varicella zoster virus packet offered to pharmacist and declined. Additional information has been requested.
not in pain unless he pinch it or push; arm on the injection site is a little bit sore; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (not in pain unless he pinch it or push) and INJECTION SITE PAIN (arm on the injection site is a little bit sore) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2021, the patient experienced PAIN (not in pain unless he pinch it or push) and INJECTION SITE PAIN (arm on the injection site is a little bit sore). At the time of the report, PAIN (not in pain unless he pinch it or push) and INJECTION SITE PAIN (arm on the injection site is a little bit sore) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Narrative: 85 yo patient with PAST MEDICAL HISTORY: 1 knee pain 2 back pain 3 GERD, hx of GI bleed 4 Hearing loss 5 COPD 6 Rosacea 7 Hypertension. 8 Colon Diverticulosis 9 Echo 06/24/99 showed ejection fraction of 45-50%. 10 Hyperlipidemia. 11 Depression 12 ckd 13 TIA 14 Peripheral neuropathy who had received covid vaccines from clinic on 1/14/21 & 2/13/2021 died of unknown causes on 9/16/2021. Patient received limited care from clinic so little info in records system on his helath. Last chart note dated 7/16/2021. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.
Reoccurring hives, had shots on Thursday, first incident of hives on Friday AM & then twice more throughout the day; again x2 on Sat and again x2 on Sunday, stopped 6 00/p Sunday evening.  Temp 99.2 (ear), no difficulty breathing or swallowing at any time; patient was given Benadryl per MD on Sat and Sunday.
parent describes 22MAY97 PM pt started c/o arm hurting;@ this time redness, hardness, warmth of arm @ inj site noted by parent;parents felt child had fever but temp not taken w/thermometer;itching;
24hr p/vax fever 101, chills, joint aches in bed for 24hr;
Right upper arm (shoulder to elbow) (surrounding vaccine site) with swelling/urticarial rxn in 24 hours after influenza vaccine. Tx=sx care (diphenhydramine, cool compresses).
Dizziness Body aches Fatigue Headache Lightheaded Skin tingling all over
onset of rash on 8/1/99, rash lasted about 7 days per mom;had fever on next day x 5 days;max T101;given APAP x 4 days;no pre-existing condition, no complications, no rx meds given;
A few days after the first dose of the Pfizer vacccine, both  ears begamn to ring and have swooshing sound.  Clinic  sent me to the ENT center..The test showed a  sligh thearing loss in both ears.
Information has been received from a registered nurse regarding a patient of unknown age and gender. On 23-FEB-2012, the patient was administered with a dose VARIVAX (Lot # 670851/0869AA, expiry date 26-JUL-2013) (Route, dosing regimen and frequency unknown) which was exposed to a temperature excursion of up to -3 degrees Centigrade. No adverse events were reported. No product quality issue was reported. This is one of the many reports received from the same source. Additional information has been requested.
I took the 2nd dose of Moderna on 14th of April. In May, I started feeling itchy at random places on my body which turned into hives if I scratched a little bit. It was not severe. So, I thought, it might be a bug bitten me. By end of June and starting of July, I started having extremely itchy skin and hives flare ups specially around 2-3 a.m. at night. After couple of weeks, my skin became extremely dry and in next few weeks I developed keratosis pillars on my arms, legs, neck and a bit on stomach. Initially thought, it might be reaction to a new body wash that I tried. It has been two months since I stopped using that body wash but there is no change in my condition. I went to see a family physician who was recommending me a steroid prednisone but I declined. Then, I went to see an allergist and he couldn?t figure out the cause as well. My blood work, food allergy test, skin test everything came out normal. These days, I am surviving on Zyrtec, Allegra and Benadryl these days. Now I am wondering if it is a delayed reaction of Moderna vaccine. That was the only change in my lifestyle and I never had such a sever allergy reaction in past were I was facing multiple skin issues all at once.
HEADACHE, INJECTION SITE REDNESS & SWELLING, FEVER, SORE SHOULDER, SORE NECK
MUSCLE ACHES; HEADACHE; FELT FATIGUE; LOW GRADE FEVER; MENTAL FOGGINESS; HARD AREA; ARM PAIN; This spontaneous report received from a parent concerned a 30 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included autoimmune issues. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 24-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested.  No concomitant medications were reported.  On 2021, the subject experienced mental fogginess. On 2021, the subject experienced hard area. On 2021, the subject experienced arm pain. On MAR-2021, the subject experienced muscle aches. On MAR-2021, the subject experienced headache. On MAR-2021, the subject experienced felt fatigue. On MAR-2021, the subject experienced low grade fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the felt fatigue, muscle aches, headache, arm pain, mental fogginess, low grade fever and hard area was not reported. This report was non-serious. This case, from the same reporter is linked to 20210422139.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure as the case is assessed non serious
HYPOTENSION 4/22/2022 ANEMIA ACUTE RESPIRATORY FAILURE 4/22/2022 ANEMIA HYPOTENSION 4/22/2022 LOCULATED PLEURAL EFFUSION ACUTE RESPIRATORY FAILURE 4/22/2022 LOCULATED PLEURAL EFFUSION HYPOTENSION 4/22/2022 ANEMIA DUE TO BLOOD LOSS ACUTE RESPIRATORY FAILURE 4/22/2022 ANEMIA DUE TO BLOOD LOSS HYPOTENSION 4/22/2022 MALIGNANT PLEURAL EFFUSION ACUTE RESPIRATORY FAILURE 4/22/2022 MALIGNANT PLEURAL EFFUSION
Child received immunizations at approximately 2 p.m.  At 3:00 p.m. the mother returned to health dept. with child and stated that he was getting hives.  Child was warm, dry and pink.  No acute distress.  Resps were regular and non-labored.  22 Ht tones regular at 120bpm.  Breath sounds clear bilaterally, child alert.  Raised hive areas noted on right wrist and left wrist to a lesser extent, no other hives noted.  Written vaccine given to mother (including stes given and mother instructed to drive to local hospital and go to ER for observation.  ER contacted by staff.  Mother agreeable to plan. 12/18/06 TC to ER dept. at hospital to check on child's status.  The ER nurse stated that his hives were resolving and that he was going to receive a dose of Benadryl and be sent home.  She stated that the raised areas wre more extensive on the right wrist. 12-19-06 TC to phone numbers available for client's parents but no working numbers available.  Unable to get any sibling information.
Patient had respiratory arrest and bradycardia requiring bag mask ventilation and chest compressions approx. 1 hr after vaccination.
Diagnosed with covid-19 on February 17th and March 18th of 2021